Skip to content
OpenCapital
Get started

Lexicon Pharmaceuticals LXRX EV / sales

EV / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.9×-4.0×
Pfizer logo
PfizerPFE
3.5×+0.3×
Merck & Co. logo
Merck & Co.MRK
5.2×+1.2×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
9×-1.9×
Cytokinetics logo
CytokineticsCYTK
79.4×-177×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
3.7×-6.9×

Other financials

Income statement

See full
Revenue$21.1M+1,572%
Gross profit$21.0M+1,604%
Operating income-$996.0K+96.1%
Net income-$1.0M+95.9%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$67.1M+6.7%
Total debt$57.7M-45.7%
Total equity$202.9M+64.9%
Total assets$268.8M-9.7%

Cash flow

See full
Operating cash flow-$14.7M+66.4%
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$986.12M+262%
Enterprise value$976.73M+209%
P/S14.2×+5.4×

Profitability

See full
Gross margin99.5%+1.5pp
Operating margin-34.8%-16.8pp
Net margin-37.5%-18.1pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-16%-7.2pp
Debt / equity0.3×-0.6×
Current ratio18.8×+16.6×

Where this comes from

Calculated from Lexicon Pharmaceuticals’s reported figures.

enterprise value/total revenue=9.4×

Based on the most recent quarter.

The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lexicon Pharmaceuticals's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lexicon Pharmaceuticals's EV / sales?
Lexicon Pharmaceuticals (LXRX) reported EV / sales of 9.4× in Q1 2026.
How has Lexicon Pharmaceuticals's EV / sales changed year-over-year?
Lexicon Pharmaceuticals's EV / sales increased by 39.1% year-over-year, from 6.7× to 9.4×.
What is the long-term trend for Lexicon Pharmaceuticals's EV / sales?
Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's EV / sales has grown at a -12.7% compound annual growth rate (CAGR), from 16.5× to 8.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.